Table 1.

Baseline demographics.

	n=10
Gender Female n( %)	7 (70)
Age at treatment (mean±SD)	39.5 ± 6.6
Race; n (%)
Caucasian	9 (90)
Hispanic	1 (10)
Cause of end stage renal disease; n (%)
Glomerulonephritis	5 (50)
Alport's syndrome	1 (10)
Cystic kidney disease	2 (20)
Congenital	2 (20)
Baseline dialysis status; n (%)
Hemodialysis	7 (70)
Peritoneal Dialysis	3 (30)
Prior kidney transplants; n (%)
0	2 (20)
1	4 (40)
2	1 (10)
3	2 (20)
more than 3	1 (10)
Donor Specific Antibody (class); n (%)
Both class I and II	9 (90)
Anti-Class II only	1 (10)
Anti-Class I only	0
B- FXM with original intended donor (mean channel shift ±SD)	532 ± 78
Baseline cPRA (MFI ± 2000)- (mean±SD)	98.2 ± 3.5
Transplantation posttreatment; n (%)	8 (80)
Time to transplantation (mean month ±SD)	31 ± 19